Insights and News
Insights and News
We here at CSC follow phenomena, trends, breakthroughs and pioneering efforts that affect our field. We are active participants in social debate and strive to influence national and international operating conditions in an effort to support our customers' success.Content with Viewpoints .
CSC offered resources in a virtual Biohackathon helping to develop new tools for COVID-19 analysis
More than 20 different projects and over 500 scientists, software developers and clinicians met in the online event from 5 to 11 April with a goal to improve the accessibility of COVID-19 data, protocols, analysis pipelines and provide dedicated compute resources to execute demanding data analysis tasks.
Read More »
The Genome Center Finland will serve as an expert on the use of genomic data
Genomic data will open up new opportunities for diagnostics and treatment of diseases. The Genome Center Finland will serve as an expert on the use of genomic data. Its task will to be to enhance the responsible use of genomic data in the promotion of human health and to administer the national genome database.
Read More »
Multifaceted nature of sensitive data allows for wide range of research
Sensitive data is any data that contains personal information, which can be used to directly identify a specific person. Sensitive data includes personal identity numbers, genetic data or spatial data. Human genetic data can be used to develop better drugs, prevent diseases and choose the best treatment, such as for cancer patients. Indeed, sensitive data is a very hot topic right now, because it has been found that it can be used in a variety of ways in different types of research.
Read More »Content with Viewpoints .
Better tailored care through advanced data transfer and analysis methods
Some of the most valuable insights generated by research come from the integration of complex datasets. It is therefore important to promote national computing and data storage services. This creates a strong foundation for data-intensive research in Finland.
Read More »
Working together towards a federated European Genome-phenome Archive for publishing and re-using sensitive research data
In January 2022, CSC as the Finnish ELIXIR Node, completed the first end-to-end test for the Federated EGA (Federated European Genome-phenome Archive): a major step towards sharing sensitive biomedical data via a network of European repositories.
Read More »
Towards digital identity wallets: with patience and through practical applications
Moving away from rigid digital identities towards solutions where the user can choose which attributes of their identity they want to share with whom seems to respond best to what is expected of electronic identity solutions nowadays. But how does this work, what does it mean and what’s CSC’s role in all this?
Read More »
Omikron-aallon huippu lähestyy - mitä SARS2-CoV -viruksesta tiedetään molekyylibiologian tasolla?
Koronapandemia on piinannut maailmaa jo kahden vuoden ajan. Tämän ja tulevien pandemioiden ehkäisyssä, hoidossa ja hallinnassa on syytä kerätä ja tutkia virusten molekyylibiologian tason dataa.
Read More »
